BIOMIMESYS® hydroscaffold is the only technology for 3D cell culture based on Hyaluronic Aid (HA) crosslinked with other extracellular matrix components (Collagens, Fibronectin fragments…). BIOMIMESYS® hydroscaffold is proposed in ready-to-use 96-well plates. With BIOMIMESYS® technology it is possible to better mimic the physiological cell microenvironment by modulating its composition, stiffness (Young modulus) and porosity. Thanks to HCS Pharma process BIOMIMESYS® is porous, and after seeding the hydroscaffold becomes translucent for microscopic observations.



Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.


Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: